Cadrenal Therapeutics (CVKD) Shares Outstanding (Diluted) (2022 - 2026)
Cadrenal Therapeutics' Shares Outstanding (Diluted) was 2.91 million in Q2 2026, up 48.5% from 1.96 million a year earlier and up 21.0% from the prior quarter.
Powered by 
Analysis
Cadrenal Therapeutics (CVKD) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Diluted) at Cadrenal Therapeutics came in at 1.99 million, up 63.5% from FY2024.
- Shares Outstanding (Diluted) has now increased for three consecutive years, with a three-year compound annual growth rate of 55.9% (FY2022 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 1.22 million in FY2024 (+35.6%), 899,510 in FY2023 (+71.0%) and 526,060 in FY2022.
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to Q1 2022.
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for 14 straight quarters, with growth averaging 53.4% over the last eight quarters.
- The year-over-year growth in Shares Outstanding (Diluted) has ranged between 7.6% (Q3 2024) and 91.6% (Q3 2023) over the last five years.
- Per Business Quant data, CVKD's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 2.41 million (Q1 2026), 1.99 million (Q4 2025) and 2.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Cadrenal Therapeutics | 557,746.58 | -12.06 Mn | - | 416,175.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 416,175.00 |
| Mar 31, 2026 | 343,952.14 |
| Dec 31, 2025 | 284,822.43 |
| Sep 30, 2025 | 292,004.71 |
| Jun 30, 2025 | 280,234.57 |
| Mar 31, 2025 | 263,438.86 |
| Dec 31, 2024 | 174,221.43 |
| Sep 30, 2024 | 157,715.00 |
| Jun 30, 2024 | 152,469.29 |
| Mar 31, 2024 | 152,469.29 |
| Dec 31, 2023 | 128,501.43 |
| Sep 30, 2023 | 146,638.00 |
| Jun 30, 2023 | 111,650.86 |
| Mar 31, 2023 | 102,600.29 |
| Dec 31, 2022 | 75,151.43 |
| Sep 30, 2022 | 76,548.71 |
| Jun 30, 2022 | 73,527.43 |
| Mar 31, 2022 | 71,432.14 |
API Access
Cadrenal Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CVKD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "CVKD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CVKD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();